Zhu Minjia, Li Xinyi, Xiao Le, Yu Kan, Li Jingyi, Dai Zixiang, Zhang Qinrou, Dai Jialiang, Jia Zihan, Bai Yuxing, Zhang Ke
Department of Orthodontics, Beijing Stomatological Hospital, School of Stomatology, Capital Medical University, Beijing, 100070, PR China.
Department of Orthodontics, Shanghai Stomatological Hospital and School of Stomatology, Fudan University, Shanghai, 200001, PR China.
Bioact Mater. 2025 May 21;51:399-413. doi: 10.1016/j.bioactmat.2025.05.011. eCollection 2025 Sep.
Regeneration of critical-sized bone defects remains a major clinical challenge. Solely promoting osteogenesis is inadequate, because vasculature and neural innervation are critical for establishing the bone regenerative microenvironment.
For the first time, the present study developed 3D bio-printed hydrogel microfibers (aMF) encapsulating human periodontal ligament stem cells (hPDLSCs) in a tri-culture system in calcium phosphate cement (CPC) scaffold with a two-stage metformin release for regeneration of nerve, vasculature, and bone.
This tri-culture system consisted of hPDLSCs, human umbilical vein endothelial cells (hUVECs), and pericytes (PCs). Moreover, we employed 3D-bioprinted aMF in CPC scaffold with a controlled two-stage release system for metformin release to promote bone, vasculature, and nerve regeneration.
Our innovative construct increased the regenerated amounts of bone, vasculature and nerve significantly by 2.5-fold, 3-fold, and 3.5-fold, respectively, than control group, in cranial defects in rats.
This novel hPDLSCs tri-culture system in aMF-CPC scaffold with two-stage metformin release is highly promising for the regeneration of all three tissues of bone, vasculature, and nerves in a wide range of craniofacial and orthopedic applications.
临界尺寸骨缺损的再生仍然是一项重大的临床挑战。仅促进成骨是不够的,因为血管系统和神经支配对于建立骨再生微环境至关重要。
本研究首次开发了一种三维生物打印水凝胶微纤维(aMF),其在磷酸钙骨水泥(CPC)支架的三培养系统中封装人牙周膜干细胞(hPDLSCs),并具有两阶段二甲双胍释放功能,用于神经、血管和骨的再生。
该三培养系统由hPDLSCs、人脐静脉内皮细胞(hUVECs)和周细胞(PCs)组成。此外,我们在CPC支架中采用具有可控两阶段释放系统的三维生物打印aMF来实现二甲双胍的释放,以促进骨、血管和神经再生。
在大鼠颅骨缺损模型中,我们创新性的构建物使骨、血管和神经的再生量分别比对照组显著增加了2.5倍、3倍和3.5倍。
这种在aMF-CPC支架中具有两阶段二甲双胍释放功能的新型hPDLSCs三培养系统在广泛的颅面和骨科应用中对骨、血管和神经这三种组织的再生具有很高的应用前景。